| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells
|
Azimi, Iman
|
|
2016
|
10 |
1 |
p. 166-178
13 p.
|
artikel
|
| 2 |
Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide
|
Ozdener, Gokhan Baris
|
|
2016
|
10 |
1 |
p. 1-23
23 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2016
|
10 |
1 |
p. ii-
1 p.
|
artikel
|
| 4 |
Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations
|
Koczorowska, M.M.
|
|
2016
|
10 |
1 |
p. 40-58
19 p.
|
artikel
|
| 5 |
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
|
Dorman, Stephanie N.
|
|
2016
|
10 |
1 |
p. 85-100
16 p.
|
artikel
|
| 6 |
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy
|
Nuciforo, Paolo
|
|
2016
|
10 |
1 |
p. 138-147
10 p.
|
artikel
|
| 7 |
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
|
Tong, Xiaoguang
|
|
2016
|
10 |
1 |
p. 113-125
13 p.
|
artikel
|
| 8 |
mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition
|
Massey, Andrew J.
|
|
2016
|
10 |
1 |
p. 101-112
12 p.
|
artikel
|
| 9 |
p53-Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study
|
Ha, Chul S.
|
|
2016
|
10 |
1 |
p. 148-156
9 p.
|
artikel
|
| 10 |
Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer
|
Liu, Chao
|
|
2016
|
10 |
1 |
p. 179-193
15 p.
|
artikel
|
| 11 |
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
|
De Marchi, Tommaso
|
|
2016
|
10 |
1 |
p. 24-39
16 p.
|
artikel
|
| 12 |
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
|
Baenke, Franziska
|
|
2016
|
10 |
1 |
p. 73-84
12 p.
|
artikel
|
| 13 |
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
|
Chang, Gregory A.
|
|
2016
|
10 |
1 |
p. 157-165
9 p.
|
artikel
|
| 14 |
Serum N-glycan analysis in breast cancer patients – Relation to tumour biology and clinical outcome
|
Haakensen, Vilde D.
|
|
2016
|
10 |
1 |
p. 59-72
14 p.
|
artikel
|
| 15 |
Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model
|
Endaya, Berwini B.
|
|
2016
|
10 |
1 |
p. 126-137
12 p.
|
artikel
|
Tijdschrift beschrijving